序号 |
标题 |
次数 |
作者 |
发布时间 |
200341 |
姜黄素聚乙二醇化脂质体(Cur-PEG-LPs),药物递送系统 |
466 |
axc |
2023-12-27 |
200342 |
双[2-(2-溴异丁酰氧基)十一烷基]二硫化物,402828-41-5 |
232 |
h |
2023-12-27 |
200343 |
硫酸长春新碱脂质体,药物递送系统,药物载体 |
301 |
axc |
2023-12-27 |
200344 |
透明质酸水凝胶 HA水凝胶生物材料 |
937 |
ssl |
2023-12-27 |
200345 |
乙二胺-N,N,N',N'-四乙酸四乙酯,CAS号:3626-00-4 |
299 |
h |
2023-12-27 |
200346 |
聚乙烯醇-壳聚糖水凝胶 PVA-壳聚糖水凝胶 |
1456 |
ssl |
2023-12-27 |
200347 |
O-(2-氨基乙基)-O'-[2-(生物素氨基)乙基]八甘醇,CAS号:960132-48-3 |
258 |
h |
2023-12-27 |
200348 |
NMFGF1-PEG+UTMD超声靶向微泡脂质体,超声靶向脂质体 |
303 |
axc |
2023-12-27 |
200349 |
丙烯酸接枝壳聚糖水凝胶 齐岳生物供应 |
473 |
ssl |
2023-12-27 |
200350 |
N-炔丙基马来酰亚胺 209395-32-4 |
256 |
h |
2023-12-27 |
200351 |
包载酸性成纤维细胞生长因子1-聚乙二醇化长循环脂质体(NMFGF1-PEG) |
267 |
axc |
2023-12-27 |
200352 |
甘草多糖壳聚糖水凝胶 齐岳生物供应水凝胶生物材料 |
359 |
ssl |
2023-12-27 |
200353 |
抗VEGFR2-奥沙利铂免疫脂质体,靶向效应 |
320 |
axc |
2023-12-27 |
200354 |
N-(1R,8S,9s)-双环[6.1.0]壬-4-炔-9-基甲氧基羰基-1,8-二氨基-3,6-二氧辛烷,1263166-93-3 |
252 |
h |
2023-12-27 |
200355 |
二硫键交联的壳聚糖-明胶水凝胶 |
737 |
ssl |
2023-12-27 |
200356 |
二硫键交联的壳聚糖-明胶水凝胶 |
968 |
ssl |
2023-12-27 |
200357 |
聚乙二醇修饰钆喷酸葡胺脂质体(PEG-Gd-DTPA),脂质体表面聚乙二醇PEG修饰 |
263 |
axc |
2023-12-27 |
200358 |
叶酸-PEG-人血清白蛋白修饰异土木香内酯靶向长循环脂质体(f-HSA-PEG-IAL脂质体) |
299 |
axc |
2023-12-27 |
200359 |
没食子儿茶素没食子酸酯/姜黄素复合脂质体(EGCG/Cur-L) |
344 |
axc |
2023-12-27 |
200360 |
1006711-90-5,Maleimide-DOTA |
288 |
h |
2023-12-27 |
200361 |
PEG修饰EGCG/Cur复合脂质体,儿茶素脂质体,姜黄素脂质体 |
310 |
axc |
2023-12-27 |
200362 |
937025-17-7,dPEG-SATA(S-acetyl-dPEG-NHS ester) |
265 |
h |
2023-12-27 |
200363 |
DL-α-硫辛酸-NHS DL-α-Lipoic Acid-NHS 40846-94-4 |
289 |
h |
2023-12-27 |
200364 |
BIS-MAL-DPEG(R)11 854753-78-9 |
268 |
h |
2023-12-27 |
200365 |
Amino-PEG12-alcohol,933789-97-0 |
254 |
h |
2023-12-27 |
200366 |
PLGA-PEG-PLGA水凝胶包载多柔比星脂质体,DOX-Lip-Gel脂质体 |
479 |
axc |
2023-12-27 |
200367 |
6-[[4-(N-马来酰亚胺甲基)环己基]甲酰胺基]己酸琥珀酰亚胺酯,125559-00-4 |
289 |
h |
2023-12-27 |
200368 |
长循环PEG-Gd-DTPA脂质体,长循环脂质体定制技术服务 |
295 |
axc |
2023-12-27 |
200369 |
6-[(tert-Butoxycarbonyl)amino]hexanoic Acid N-Succinimidyl Ester 51513-80-5 |
250 |
h |
2023-12-27 |
200370 |
Gd-DTPA脂质体,脂质体包裹Gd-DTPA,脂质体表面修饰定制服务 |
408 |
axc |
2023-12-27 |
200371 |
5-叠氮基缬草酸 5-Azidovaleric Acid 79583-98-5 |
295 |
h |
2023-12-27 |
200372 |
5-叠氮基-2-硝基苯甲酸-N-琥珀酰亚胺酯 N-Succinimidyl 5-Azido-2-nitrobenzoate 60117-35-3 |
249 |
h |
2023-12-27 |
200373 |
4-叠氮基-2,3,5,6-四氟苯甲酸 4-Azido-2,3,5,6-tetrafluorobenzoic Acid 122590-77-6 |
284 |
h |
2023-12-27 |
200374 |
RGD(精氨酸-甘氨酸-天冬氨酸,Arg-Gly-Asp)共修饰脂质体,RGD修饰脂质体,C/RGD-LP |
443 |
axc |
2023-12-27 |
200375 |
二硬脂酰磷脂酰乙醇胺-聚乙二醇化大黄素脂质体,DSPE-Emo-Lip |
262 |
axc |
2023-12-27 |
200376 |
PEG修饰依托泊苷长循环脂质体(PEG-ETP-LP),一种药物递送系统 |
320 |
axc |
2023-12-27 |
200377 |
4-[3-(三氟甲基)-3H-双吖丙啶-3-基]苄胺盐酸盐 4-[3-(Trifluoromethyl)-3H-diazirin-3-yl]benzylamine Hydrochloride 1258874-29-1 |
294 |
h |
2023-12-27 |
200378 |
4-(4-马来酰亚胺基苯基)丁酸-N-琥珀酰亚胺酯 N-Succinimidyl 4-(4-Maleimidophenyl)butyrate 79886-55-8 |
323 |
h |
2023-12-27 |
200379 |
药物载体非PEG空白脂质体,非PEG脂质体特点和应用 |
313 |
axc |
2023-12-27 |
200380 |
3-马来酰亚胺基苯甲酸-N-琥珀酰亚胺酯 N-Succinimidyl 3-Maleimidobenzoate |
372 |
h |
2023-12-27 |
200381 |
聚(2-乙基-2-噁唑啉)-胆固醇氯甲酸酯修饰盐酸阿霉素脂质体 |
265 |
axc |
2023-12-27 |
200382 |
PEG修饰水飞蓟素脂质体,空白脂质体,应用于不同种类的药物 |
393 |
axc |
2023-12-27 |
200383 |
聚乙二醇包覆维生素C脂质体,提高其稳定性、溶解度和生物利用度 |
492 |
axc |
2023-12-27 |
200384 |
PEG表面修饰黄芩苷脂质体,PEG修饰脂质体,亲水性脂质体产品 |
328 |
axc |
2023-12-27 |
200385 |
TAT-PEG-多功能脂质体,细胞穿膜肽PEG脂质体定制服务 |
240 |
axc |
2023-12-27 |